Pharmacokinetics of atazanavir/ritonavir once daily and lopinavir/ritonavir twice and once daily over 72 h following drug cessation.
about
Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapySequential population pharmacokinetic modeling of lopinavir and ritonavir in healthy volunteers and assessment of different dosing strategiesEvolution of drug-resistant viral populations during interruption of antiretroviral therapyPharmacokinetics of once-daily darunavir-ritonavir and atazanavir-ritonavir over 72 hours following drug cessation.Improved oral bioavailability of lopinavir in melt-extruded tablet formulation reduces impact of third trimester on lopinavir plasma concentrations.Estimation of the effect of SLCO1B1 polymorphisms on lopinavir plasma concentration in HIV-infected adults.Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100 mg, 200/150 mg and 200/50 mg twice daily in HIV-negative volunteers.Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteersDosing antiretroviral medication when crossing time zones: a review.A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
P2860
Q28478666-F3FE72AB-029E-4857-AF33-E3F7F57C2B60Q35005222-CC4A5CB9-D887-4BBC-BA21-10E420610B18Q35077423-C441F7FD-1052-4E81-927C-C90DF7A588BAQ35191614-86D74321-BAA2-4555-A5E4-05DA2ED246BCQ35689226-E857C09D-47B8-4A22-B0E6-5AA9424D77FAQ36238198-036ACB59-E77D-4725-9C1F-98E81FA47321Q36676533-B2B4BEE8-187C-4EC6-8BDE-0280F0EAC15AQ37187471-1EE8DD3D-7FF9-464E-93F1-5ABBCD6EDDD2Q38674015-26109627-239A-4FD5-B47C-EF9D5EC74A67Q41926207-0A8D4C6E-FDB3-4856-92E2-0CCE10F32FAE
P2860
Pharmacokinetics of atazanavir/ritonavir once daily and lopinavir/ritonavir twice and once daily over 72 h following drug cessation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Pharmacokinetics of atazanavir ...... 72 h following drug cessation.
@en
Pharmacokinetics of atazanavir ...... 72 h following drug cessation.
@nl
type
label
Pharmacokinetics of atazanavir ...... 72 h following drug cessation.
@en
Pharmacokinetics of atazanavir ...... 72 h following drug cessation.
@nl
prefLabel
Pharmacokinetics of atazanavir ...... 72 h following drug cessation.
@en
Pharmacokinetics of atazanavir ...... 72 h following drug cessation.
@nl
P2093
P1433
P1476
Pharmacokinetics of atazanavir ...... 72 h following drug cessation.
@en
P2093
Anton Pozniak
Brian Gazzard
David Back
Graeme Moyle
Jessica Taylor
Laura Else
Marta Boffito
Marta Sousa
P304
P577
2008-01-01T00:00:00Z